Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE TABLETS and METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE TABLETS and METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METHYLPHENIDATE HYDROCHLORIDE tablets, for oral use, CII METHYLPHENIDATE HYDROCHLORIDE extended-release tablets, for oral use, CII Initial U.S. Approval: 1955
Medication labelWhy this: Advisory · dailymed-prescription
Methylphenidate hydrochloride tablets and methylphenidate hydrochloride extended-release tablets are indicated for the treatment of: Attention Deficit Hyperactivity Disorders (ADHD) in pediatric patients 6 years and older and adults Narcolepsy
- generic_name
- methylphenidate hydrochloride
- product_names
- Methylphenidate Hydrochloride
- ndc
- 68084-805, 68084-823, 0406-1142, 68084-805-11, 68084-805-21, 0406-1144, 68084-823-11, 68084-823-21
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en